DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
4QVL_B_BO2B201 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVL_H_BO2H301 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
9 |
THR H 1SER H 20GLN H 22LYS H 33ALA H 46ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVL_K_BO2K301 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
4QVL_N_BO2N201 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVL_V_BO2V301 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
10 |
THR V 1SER V 20GLN V 22LYS V 33ALA V 46THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVL_Y_BO2Y301 |
4qvl |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
4QVM_B_BO2B201 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVM_H_BO2H301 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
10 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVM_K_BO2K301 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
4QVM_N_BO2N201 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVM_V_BO2V301 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
10 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVM_Y_BO2Y301 |
4qvm |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33GLY Y 47GLY Y 48ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
4QVN_B_BO2B201 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
12 |
THR b 1THR b 20THR b 21THR b 22ALA b 27LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVN_H_BO2H301 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVN_K_BO2K301 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33VAL K 45GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
4QVN_N_BO2N201 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR N 1THR N 20THR N 21THR N 22ALA N 27LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVN_V_BO2V301 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
10 |
THR V 1SER V 20GLN V 22LYS V 33GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVN_Y_BO2Y301 |
4qvn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33VAL Y 45GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QVP_B_BO2B201 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVP_H_BO2H301 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVP_K_BO2K301 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33THR K 45GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
4QVP_N_BO2N201 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVP_V_BO2V301 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVP_Y_BO2Y301 |
4qvp |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33THR Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QVQ_B_BO2B201 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVQ_H_BO2H301 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVQ_K_BO2K301 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33ILE K 45GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
4QVQ_N_BO2N201 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVQ_V_BO2V301 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
11 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVQ_Y_BO2Y301 |
4qvq |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33ILE Y 45GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QVV_B_BO2B201 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
10 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVV_H_BO2H301 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
13 |
THR H 1SER H 20THR H 21GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVV_K_BO2K301 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
8 |
THR K 1THR K 21LYS K 33MET K 45GLY K 47GLY K 48VAL K 49ASP L 126 |
BO2 K 301
|
4QVV_N_BO2N201 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
10 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVV_V_BO2V301 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
13 |
THR V 1SER V 20THR V 21GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVV_Y_BO2Y301 |
4qvv |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
8 |
THR Y 1THR Y 21LYS Y 33MET Y 45GLY Y 47GLY Y 48VAL Y 49ASP Z 126 |
BO2 Y 301
|
4QVW_B_BO2B201 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVW_H_BO2H301 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
10 |
THR H 1SER H 20GLN H 22LYS H 33ALA H 46THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVW_K_BO2K301 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48SER K 49ASP L 126SER L 130 |
BO2 K 301
|
4QVW_N_BO2N201 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVW_V_BO2V301 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
10 |
THR V 1SER V 20GLN V 22LYS V 33ALA V 46THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVW_Y_BO2Y301 |
4qvw |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48SER Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
4QVY_B_BO2B201 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45SER b 46ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QVY_H_BO2H301 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
13 |
THR H 1SER H 20THR H 21GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QVY_K_BO2K301 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27VAL K 31LYS K 33GLY K 48THR K 49ASP L 126 |
BO2 K 301
|
4QVY_N_BO2N201 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45SER N 46ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QVY_V_BO2V301 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QVY_Y_BO2Y301 |
4qvy |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27VAL Y 31LYS Y 33GLY Y 48THR Y 49ASP Z 126 |
BO2 Y 301
|
4QW0_B_BO2B201 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QW0_H_BO2H301 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QW0_K_BO2K301 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5 |
PF00227(Proteasome) |
7 |
THR K 1ALA K 20THR K 21ALA K 22LYS K 33MET K 45THR K 49 |
BO2 K 301
|
4QW0_N_BO2N201 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QW0_V_BO2V301 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
11 |
THR V 1SER V 20GLN V 22LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QW0_Y_BO2Y301 |
4qw0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5 |
no annotation |
7 |
THR Y 1ALA Y 20THR Y 21ALA Y 22LYS Y 33MET Y 45THR Y 49 |
BO2 Y 301
|
4QW1_B_BO2B201 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QW1_H_BO2H301 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QW1_K_BO2K301 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
4QW1_N_BO2N201 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QW1_V_BO2V301 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QW1_Y_BO2Y301 |
4qw1 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QW3_B_BO2B201 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QW3_H_BO2H301 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
10 |
THR H 1SER H 20GLN H 22LYS H 33ALA H 46THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QW3_K_BO2K301 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
4QW3_N_BO2N201 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QW3_V_BO2V301 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
11 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QW3_Y_BO2Y301 |
4qw3 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
4QWU_B_BO2B201 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
4QWU_H_BO2H301 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
4QWU_K_BO2K301 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ASP L 126 |
BO2 K 301
|
4QWU_N_BO2N201 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
4QWU_V_BO2V301 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
11 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
4QWU_Y_BO2Y301 |
4qwu |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ASP Z 126 |
BO2 Y 301
|
5BXN_B_BO2B201 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
5BXN_H_BO2H301 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
5BXN_K_BO2K301 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5BXN_N_BO2N201 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
5BXN_V_BO2V301 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
11 |
THR V 1SER V 20THR V 21GLN V 22LYS V 33ALA V 46GLY V 47THR V 48ALA V 49ASP W 124CYS W 128 |
BO2 V 301
|
5BXN_Y_BO2Y301 |
5bxn |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5CZ7_B_BO2B201 |
5cz7 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
9 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45ALA b 49THR b 52SER V 118 |
BO2 b 201
|
5CZ7_H_BO2H301 |
5cz7 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33ALA H 46THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
5CZ7_N_BO2N201 |
5cz7 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
5CZ7_V_BO2V301 |
5cz7 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
5D0X_B_BO2B201 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
5D0X_H_BO2H301 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR H 1SER H 20THR H 21GLN H 22CYS H 31LYS H 33ALA H 46THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
5D0X_K_BO2K301 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
9 |
SER K 1ALA K 20THR K 21ALA K 27LYS K 33GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
5D0X_N_BO2N201 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
5D0X_V_BO2V301 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
13 |
THR V 1SER V 20THR V 21GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
5D0X_Y_BO2Y301 |
5d0x |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
no annotation |
9 |
SER Y 1ALA Y 20THR Y 21ALA Y 27LYS Y 33GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|
5L5F_B_BO2B201 |
5l5f |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45SER b 46ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
5L5F_H_BO2H301 |
5l5f |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
5L5F_K_BO2K301 |
5l5f |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
PF00227(Proteasome) |
9 |
THR K 1SER K 21SER K 27VAL K 31LYS K 33MET K 45ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5L5F_N_BO2N201 |
5l5f |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45SER N 46ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
5L5F_V_BO2V301 |
5l5f |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
5L5F_Y_BO2Y301 |
5l5f |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
no annotation |
8 |
THR Y 1SER Y 21SER Y 27LYS Y 33MET Y 45ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5L5Z_B_BO2B201 |
5l5z |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
12 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45SER b 46GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
5L5Z_H_BO2H301 |
5l5z |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR H 1SER H 20THR H 21GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
5L5Z_K_BO2K301 |
5l5z |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5;PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6 |
PF00227(Proteasome) |
9 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27LYS K 33GLY K 47ALA K 49ASP L 126 |
BO2 K 301
|
5L5Z_N_BO2N201 |
5l5z |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45SER N 46GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
5L5Z_V_BO2V301 |
5l5z |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20THR V 21GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
5L5Z_Y_BO2Y301 |
5l5z |
BO2 DB00188(Bortezomib) |
Homo sapiens;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-5,PROTEASOMESUBUNIT BETA TYPE-5;PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6 |
no annotation |
9 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27LYS Y 33GLY Y 47ALA Y 49ASP Z 126 |
BO2 Y 301
|
5L66_B_BO2B201 |
5l66 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
11 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
5L66_H_BO2H301 |
5l66 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR H 1SER H 20GLN H 22CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124CYS I 128 |
BO2 H 301
|
5L66_K_BO2K301 |
5l66 |
BO2 DB00188(Bortezomib) |
Mus musculus;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
PF00227(Proteasome) |
10 |
THR K 1ALA K 20THR K 21SER K 27LYS K 33MET K 45GLY K 47ALA K 49ASP L 126SER L 130 |
BO2 K 301
|
5L66_N_BO2N201 |
5l66 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
5L66_V_BO2V301 |
5l66 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
no annotation |
12 |
THR V 1SER V 20GLN V 22CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
5L66_Y_BO2Y301 |
5l66 |
BO2 DB00188(Bortezomib) |
Mus musculus;Saccharomycescerevisiae |
PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6;PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5 |
no annotation |
10 |
THR Y 1ALA Y 20THR Y 21SER Y 27LYS Y 33MET Y 45GLY Y 47ALA Y 49ASP Z 126SER Z 130 |
BO2 Y 301
|
5LF3_B_BO2B305 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7 |
PF00227(Proteasome)PF10584(Proteasome_A_N)no annotation |
14 |
THR b 1THR b 20THR b 21THR b 22LYS b 33ARG b 45SER b 46GLY b 47ALA b 49THR b 52MET b 95TYR V 114SER V 118SER b 169 |
BO2 b 305
|
5LF3_H_BO2H306 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
10 |
THR H 1ALA H 20THR H 21GLU H 22CYS H 31ALA H 46GLY H 47ALA H 49THR H 52ASP I 124 |
BO2 H 306
|
5LF3_K_BO2K305 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 22LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 125TYR K 169 |
BO2 K 305
|
5LF3_N_BO2N304 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
14 |
THR N 1THR N 20THR N 21THR N 22LYS N 33ARG N 45SER N 46GLY N 47ALA N 49THR N 52MET N 95TYR H 114SER H 118SER N 169 |
BO2 N 304
|
5LF3_V_BO2V303 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7 |
no annotation |
10 |
THR V 1ALA V 20THR V 21GLU V 22LYS V 33ALA V 46GLY V 47ALA V 49THR V 52ASP W 124 |
BO2 V 303
|
5LF3_Y_BO2Y305 |
5lf3 |
BO2 DB00188(Bortezomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
no annotation |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 22LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 125TYR Y 169 |
BO2 Y 305
|
5LF7_B_6V8B304 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7 |
NonePF00227(Proteasome)PF10584(Proteasome_A_N) |
12 |
THR b 2THR b 21THR b 22THR b 23ALA b 28LYS b 34ARG b 46SER b 47GLY b 48ALA b 50THR b 53TYR V 115 |
6V8 b 304
|
5LF7_H_6V8H305 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7 |
PF00227(Proteasome)PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 2ALA H 21THR H 22GLU H 23CYS H 32ALA H 47GLY H 48ALA H 50THR H 53ASP I 124LEU I 125 |
6V8 H 305
|
5LF7_K_6V8K305 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
PF00227(Proteasome) |
11 |
THR K 2ALA K 21THR K 22ALA K 23VAL K 32LYS K 34MET K 46GLY K 48GLY K 49ALA K 50ASP L 125 |
6V8 K 305
|
5LF7_N_6V8N305 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-6;PROTEASOME SUBUNITBETA TYPE-7 |
PF00227(Proteasome)PF00227(Proteasome)PF12465(Pr_beta_C) |
12 |
THR N 2THR N 21THR N 22THR N 23ALA N 28LYS N 34ARG N 46SER N 47GLY N 48ALA N 50THR N 53TYR H 115 |
6V8 N 305
|
5LF7_V_6V8V303 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-3;PROTEASOME SUBUNITBETA TYPE-7 |
None |
11 |
THR V 2ALA V 21THR V 22GLU V 23CYS V 32ALA V 47GLY V 48ALA V 50THR V 53ASP W 124LEU W 125 |
6V8 V 303
|
5LF7_Y_6V8Y306 |
5lf7 |
6V8 DB09570(Ixazomib) |
Homo sapiens |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-5 |
None |
11 |
THR Y 2ALA Y 21THR Y 22ALA Y 23VAL Y 32LYS Y 34MET Y 46GLY Y 48GLY Y 49ALA Y 50ASP Z 125 |
6V8 Y 306
|
6HWD_B_BO2B201 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
NonePF00227(Proteasome)PF10584(Proteasome_A_N) |
12 |
THR b 1THR b 20THR b 21THR b 22ALA b 27LYS b 33ARG b 45GLY b 47ALA b 49THR b 52HIS V 114SER V 118 |
BO2 b 201
|
6HWD_H_BO2H301 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
PF00227(Pr_beta_C)PF12465(Proteasome)PF00227(Proteasome) |
12 |
THR H 1SER H 20GLN H 22ALA H 27CYS H 31LYS H 33ALA H 46GLY H 47THR H 48ALA H 49THR H 52ASP I 124 |
BO2 H 301
|
6HWD_K_BO2K301 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
PF00227(Proteasome) |
11 |
THR K 1ALA K 20THR K 21ALA K 22ALA K 27LYS K 33MET K 45GLY K 47GLY K 48ALA K 49ASP L 126 |
BO2 K 301
|
6HWD_N_BO2N201 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-1;PROTEASOME SUBUNITBETA TYPE-2 |
PF00227(Pr_beta_C)PF12465(Proteasome)PF00227(Proteasome) |
12 |
THR N 1THR N 20THR N 21THR N 22ALA N 27LYS N 33ARG N 45GLY N 47ALA N 49THR N 52HIS H 114SER H 118 |
BO2 N 201
|
6HWD_V_BO2V301 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-2;PROTEASOME SUBUNITBETA TYPE-3 |
None |
13 |
THR V 1SER V 20GLN V 22ALA V 27CYS V 31LYS V 33ALA V 46GLY V 47THR V 48ALA V 49THR V 52ASP W 124CYS W 128 |
BO2 V 301
|
6HWD_Y_BO2Y301 |
6hwd |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME SUBUNITBETA TYPE-5;PROTEASOME SUBUNITBETA TYPE-6 |
None |
11 |
THR Y 1ALA Y 20THR Y 21ALA Y 22ALA Y 27LYS Y 33MET Y 45GLY Y 47GLY Y 48ALA Y 49ASP Z 126 |
BO2 Y 301
|